Nyumbani › Dermatitis ya Atopiki (Ekzema) › Arkansas
Majaribio ya kliniki ya Dermatitis ya Atopiki (Ekzema) katika jimbo la Arkansas
Masomo 8 ya Dermatitis ya Atopiki (Ekzema) yanatafuta washiriki katika vituo vya jimbo la Arkansas.
Miji katika jimbo la Arkansas
Maandishi rasmi ya utafiti (Kiingereza)
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Fort Smith
InaajiriHatua 2
Umri 18 hadi 100 · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT06947993Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Hot Springs
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT07298395A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Arkansas Research Trials, North Little Rock
InaajiriHatua 3
Umri 2 hadi 11 · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT06807281A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Dermatology Trial Associates, Inc, Bryant
InaajiriHatua 2
Umri 18 hadi 65 · Jinsia zote · Imesasishwa 28 Ago 2026 · NCT07599813A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- Applied Research Center and Wellness Clinic /ID# 268547, Little Rock
InaajiriHatua 3
Umri 2 hadi 11 · Jinsia zote · Imesasishwa 6 Ago 2026 · NCT06461897A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
- Leo Pharma Investigational site, North Little Rock
InaajiriHatua 3
6 Months – 11 Years · Jinsia zote · Imesasishwa 7 Jul 2026 · NCT06311682A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- Clinical Trials Institute - Northwest Arkansas /ID# 267290, Fayetteville
InaajiriHatua 3
Umri 18 hadi 63 · Jinsia zote · Imesasishwa 6 Jul 2026 · NCT06389136A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
- Arkansas Research Trials, North Little Rock
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 19 Sep 2025 · NCT06055361Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.